Agentix Corp. (AGTX): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$0.01
Year ended 2026-03-31
2015-08-31: -$0.032016-08-31: -$0.052024-03-31: -$0.012025-03-31: -$0.012026-03-31: -$0.01-$0.01
2015-08-31 EPS (Diluted) (USD per share) 2026-03-31
Period endedEPS (Diluted)Change YoYSource filing
2026-03-31-$0.01n/m2026-07-01, From 2025-04-01
2025-03-31-$0.01n/m2026-07-01, From 2024-04-01
2024-03-31-$0.01n/a2025-07-16, From 2023-04-01
No annual figure between 2016-08-31 and 2024-03-31.
2016-08-31-$0.05n/m2016-12-12, From 2015-09-01
2015-08-31-$0.03n/a2016-12-12, From 2014-09-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Agentix Corp. (AGTX)2026-03-31-$0.01n/m
Mosaic ImmunoEngineering Inc. (CPMV)2025-12-31-$0.10n/m
Liminatus Pharma, Inc. (LIMN)2025-12-31-$0.43n/m
Adaptin Bio, Inc. (APTN)2025-12-31-$0.66n/m
Brainstorm Cell Therapeutics Inc. (BCLI)2025-12-31-$1.11n/m
Abpro Holdings, Inc. (ABPO)2025-12-31-$1.30n/m
Zeo ScientifiX, Inc. (ZEOX)2025-10-31-$0.86n/m
Zivo Bioscience, Inc. (ZIVO)2024-12-31-$4.23n/m
Estrella Immunopharma, Inc. (ESLA)2025-12-31-$0.35n/a

Compare AGTX, CPMV, LIMN, APTN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗